Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2717 (LINC02717) is a non-coding RNA gene in humans with transcripts that do not overlap protein-coding regions and lack large open reading frames[1][3][5][7]. LINC02717 belongs to the subclass called long intergenic non-coding RNAs (lincRNAs), which are typically more than 200 nucleotides in length and are known to play roles in regulating chromatin structure, gene transcription, and neighbouring gene expression[3][5][7]. Most lincRNAs are nuclear and can function in both *cis* and *trans* regulatory processes, but only a small fraction have been functionally characterized. There is no direct evidence that LINC02717 itself is involved in any specific disease, nor are there known drugs or clinical biomarkers based on this molecule. Its classification as a lincRNA indicates it may act as a cellular regulator, but further research would be needed to clarify any precise role or disease association[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2717 (LINC02717).